Literature DB >> 19996531

Tissue factor and cardiovascular disease: quo vadis?

Alexander Breitenstein1, Felix C Tanner, Thomas F Lüscher.   

Abstract

The coagulation cascade represents a system of proteases responsible to maintain vascular integrity and to induce rapid clot formation after vessel injury. Tissue factor (TF), the key initiator of the coagulation cascade, binds to factor VIIa and thereby activates factor IX and factor X, resulting in thrombus formation. Different stimuli enhance TF gene expression in endothelial and vascular smooth muscle cells. In addition to these vascular cells, TF has recently been detected in the bloodstream in circulating cells such as leukocytes and platelets, as a component of microparticles, and as a soluble, alternatively spliced form of TF. Various cardiovascular risk factors like hypertension, diabetes, and dyslipidemia, increase levels of TF. In line with this observation, enhanced vascular TF expression occurs during atherogenesis, particularly in patients with acute coronary syndromes. (Circ J 2010; 74: 3 - 12).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996531     DOI: 10.1253/circj.cj-09-0818

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  29 in total

1.  Blood-born tissue factor in cardiovascular disease: where are we now?

Authors:  Vincenzo Toschi
Journal:  Intern Emerg Med       Date:  2010-09-18       Impact factor: 3.397

2.  Thrombogenic potential of transcatheter aortic valve implantation with trivial paravalvular leakage.

Authors:  Lawrence N Scotten; Rolland Siegel
Journal:  Ann Transl Med       Date:  2014-05

Review 3.  Microvesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.

Authors:  Ying Wang; Li-ming Chen; Ming-lin Liu
Journal:  Acta Pharmacol Sin       Date:  2014-03-10       Impact factor: 6.150

4.  Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events.

Authors:  Anetta Undas; Agnieszka Slowik; Matthew Gissel; Kenneth G Mann; Saulius Butenas
Journal:  Eur J Clin Invest       Date:  2011-06-27       Impact factor: 4.686

Review 5.  Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

Authors:  Giovanni Cimmino; Plinio Cirillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

6.  Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; Tanya Wolfson; Anthony C Gamst; José S Loredo; Joel E Dimsdale
Journal:  Sleep Med       Date:  2012-10-01       Impact factor: 3.492

Review 7.  Bioengineered in vitro models of thrombosis: methods and techniques.

Authors:  Yu Shrike Zhang; Rahmi Oklu; Hassan Albadawi
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

8.  Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.

Authors:  Hui Zhang; Chun Gao; Long Fang; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 9.  Role of tissue factor in atherothrombosis.

Authors:  A Phillip Owens; Nigel Mackman
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

Review 10.  Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.

Authors:  Fabio Marsico; Milena Cecere; Antonio Parente; Stefania Paolillo; Fabiana de Martino; Santo Dellegrottaglie; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.